Management Impact of <sup>68</sup>Ga-DOTATATE PET/CT in Neuroendocrine Tumors.

Anderson, Redmond-Craig; Velez, Erik M; Desai, Bhushan; Jadvar, Hossein

Management Impact of ⁶⁸Ga-DOTATATE PET/CT in Neuroendocrine Tumors.

Anderson, Redmond-Craig; Velez, Erik M; Desai, Bhushan; Jadvar, Hossein.

Afiliación

Anderson RC; Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine, University of Southern California, 2250 Alcazar St., CSC 102, Los Angeles, CA 90033 USA.
Velez EM; Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine, University of Southern California, 2250 Alcazar St., CSC 102, Los Angeles, CA 90033 USA.
Desai B; Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine, University of Southern California, 2250 Alcazar St., CSC 102, Los Angeles, CA 90033 USA.
Jadvar H; Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine, University of Southern California, 2250 Alcazar St., CSC 102, Los Angeles, CA 90033 USA.

Nucl Med Mol Imaging ; 55(1): 31-37, 2021 Feb.

Article en En | MEDLINE | ID: mdl-33643487

Palabras clave

68Ga-DOTATATE; Neuroendocrine; PET; Somatostatin; Tumor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Nucl Med Mol Imaging Año: 2021 Tipo del documento: Article Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google